CDMO News
Apertus Pharmaceuticals and API Innovation Center Join Forces for Lomustine
API Innovation Center, a drug development organisation, has achieved a significant milestone in the production of lomustine, a crucial medication used in the treatment of glioblastoma, the most common and aggressive form of malignant brain cancer. The API Innovation Center
15 April 2024